Hangzhou HEO expands rapid veterinary diagnostics portfolio

Hangzhou HEO Technology Co., Ltd. is broadening its rapid diagnostic lineup for veterinary, food safety and human testing as demand rises for faster animal health monitoring. The company says its portfolio spans more than 100 product types and serves customers in more than 100 countries and regions.

Why it matters: - Rapid animal testing can help farms, clinics and labs spot disease sooner, support isolation and treatment decisions, and reduce delays when full laboratory access is limited. - Livestock outbreaks can affect animal welfare, production efficiency, trade and supply continuity. - Buyers in diagnostic markets increasingly want dependable supply, documentation and products that fit different testing environments.

What happened: - Hangzhou HEO Technology Co., Ltd., founded in 2011 and based in Hangzhou, Zhejiang, China, is expanding its role as a veterinary test manufacturer. - The company is adding rapid diagnostic products across veterinary, food safety and human testing categories. - HEO says its business reaches more than 100 countries and regions.

The details: - HEO’s veterinary portfolio covers swine, poultry, ruminants, dogs and cats. - The company lists applications in breeding plants, farms, laboratories, pet shops, veterinary clinics and veterinary hospitals. - Publicly listed veterinary tests include products for African swine fever, porcine diseases, avian influenza, avian infectious diseases, bovine brucellosis, canine heartworm, feline leukemia virus, feline immunodeficiency virus and feline panleukopenia. - HEO says its product portfolio includes more than 100 types. - The company says its products are manufactured under ISO 9001:2015 and ISO 13485:2016 quality management systems. - Public certification information also lists ISO 14001, ISO 45001, CE certification and other market- or product-specific approvals. - Certification information includes a China Ministry of Agriculture and Rural Affairs certificate tied to an African Swine Fever virus rapid test kit. - HEO says it maintains GMP-related production facilities. - The company’s food safety portfolio includes tests for aflatoxins, tetracyclines, sulfonamides, amantadine, cyromazine, nicarbazin and other targets. - HEO says its food safety materials cover milk, meat, eggs, grains, fruits and vegetables. - The human test portfolio includes products for infectious diseases, respiratory conditions, hormones, drugs of abuse, tumor and cardiac markers, and semi-quantitative testing. - Publicly listed human tests include HIV, influenza and COVID-19 combinations, typhoid, chlamydia, vitamin D, TSH and HbA1c. - HEO says its veterinary product pages include test cassettes with components such as swabs, buffers, droppers and instructions, depending on the product. - The company says OEM and ODM services are available, along with customization for certain products and packaging solutions.

Between the lines: - HEO is building around a multi-category diagnostics model, not just veterinary testing. - That structure can appeal to distributors and professional buyers looking to source several rapid diagnostic lines from one manufacturer. - The overlap between veterinary health and food safety shows how testing demand stretches across farms and the broader supply chain. - Regulatory requirements still vary by market, so product-specific approval matters more than broad company-level certifications.

What's next: - HEO says it will keep developing new products based on market requirements. - The company’s portfolio appears to be expanding as veterinary medicine leans more on earlier detection and practical testing workflows. - International buyers will likely continue to evaluate product fit, documentation and local regulatory status before purchasing.

The bottom line: - Hangzhou HEO is positioning itself as a broad rapid diagnostics supplier with veterinary, food safety and human test products under one roof.